Improving of epidemiological situation of hepatitis B was reached by universal vaccination of infants, adolescents and vaccination of adults in high risk groups. Elimination of cases in the age group 0-10 and decreasing about 90% of number of notified cases observed in the years 1989-2004 was observed. Changes of the programme of vaccination since 2008 would be necessary to introduce. The first group of children vaccinated basically in the first year of life would grow up then to 14. Resignation of basic vaccination in 14 is necessary. Introducing of booster dose seems to be available in 14, opposite immunological memory, because: very high incidence rate of hepatitis B in past was noted in Poland; still now high incidence rate is noted in the groups 15-19 and 20-24 also in some voyvodships; documented immunological memory lasts only 15 years. This problem should be evaluated during routine vaccination and scheme of vaccination should be changed as soon as possible, not later than after 5 years. Except vaccination also improving of sterilization of medical and cosmetic equipment in autoclaves and hygiene measures especially in voyvodships: łódzkie, świqtokrzyskie, kujawsko-pomorskie and dolnoślaske where rate of hepatitis B is the highest is necessery.
Download full-text PDF |
Source |
|---|
Publication Analysis
Top Keywords
Similar Publications
Do Risk Factors for HCC Impact the Association of CT/MRI LIRADS Major Features With HCC? An Individual Participant Data Meta-Analysis.
Can Assoc Radiol J
December 2024
Rm c-159 Departments of Radiology and Epidemiology, University of Ottawa, Ottawa, ON, Canada.
Guidelines suggest the Liver Imaging Reporting and Data System (LI-RADS) may not be applicable for some populations at risk for hepatocellular carcinoma (HCC). However, data assessing the association of HCC risk factors with LI-RADS major features are lacking. To evaluate whether the association between HCC risk factors and each CT/MRI LI-RADS major feature differs among individuals at-risk for HCC.
View Article and Find Full Text PDFResidual HCV-RNA and Elevated Platelet-to-Lymphocyte Ratio Predict Poor Long-Term Outcomes in Patients with Chronic Hepatitis C After Treatment.
Infect Dis Ther
December 2024
Division of Tropical Medicine and Epidemiology, Division of Tropical and Parasitic Diseases, Institute of Maritime and Tropical Medicine, Faculty of Health Sciences, Medical University of Gdansk, Powstania Styczniowego 9B, 81-519, Gdynia, Poland.
Introduction: Despite achieving sustained viral response (SVR) after treatment with direct-acting antivirals (DAAs), the risk of liver disease progression and extrahepatic complications in chronic hepatitis C (CHC) remains. We aimed to determine the role of residual HCV-RNA in peripheral blood mononuclear cells (PBMCs), a condition known as occult hepatitis C (OCI), and systemic inflammatory markers as predictors of long-term outcomes in patients treated with DAAs.
Methods: We followed 42 patients treated with DAAs with OCI status determined after therapy, for a median of 6.
A Sleeping Giant: Late HBV Reactivation After Rituximab-Based Chemotherapy Despite Correct Prophylaxis.
Int Med Case Rep J
December 2024
Clinical Department of Infectious Diseases and Hepatology, Wroclaw Medical University, Wroclaw, Poland.
Hepatitis B virus (HBV) reactivation is a recognized complication of long-term immunosuppressive or cytotoxic therapy, typically occurring during immunosuppression or within a few months after treatment. To mitigate this risk, hepatological societies recommend the use of nucleos(t)ide analogues (NA) for HBV reactivation prophylaxis, along with post-treatment monitoring; though, these recommendations are not universally consistent across different guidelines. We present a case of late HBV reactivation in a 76-year-old male with occult HBV infection who received rituximab-based therapy for chronic lymphocytic leukemia.
View Article and Find Full Text PDFVaricella-zoster virus hepatitis - a rare complication of primary infection in immunocompetent children?
Clin Exp Hepatol
September 2024
Pediatric Infectious Diseases Department, Regional Hospital of Infectious Diseases in Warsaw, Warsaw, Poland.
Aim Of The Study: This research aimed to investigate the incidence and course of varicella-zoster virus hepatitis in immunocompetent children.
Material And Methods: Medical charts of children hospitalised between 2019 and 2022 (excluding the period of the COVID-19 pandemic) due to varicella were retrospectively analysed and compared.
Results: In total, 216 children were included in the analysis.
Treatment of HCV infection in patients with steatotic liver disease.
Clin Exp Hepatol
September 2024
Faculty of Medicine, Medical University of Białystok, Białystok, Poland.
Aim Of The Study: The aim of the study was to characterize the population with hepatitis C virus (HCV) infection and steatotic liver disease (SLD) in comparison to the non-SLD HCV-infected patients and to evaluate the effectiveness of treatment with direct-acting antivirals (DAA).
Material And Methods: The analysis included 62 patients diagnosed with SLD and 14,284 non-SLD patients from the EpiTer-2 database for the period 2015-2022.
Results: Unlike the non-SLD population, the SLD group was dominated by men (49.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!